United Therapeutics Corporation (UTHR) Earnings Yield: 4.96%
Is United Therapeutics Corporation’s earnings yield high or low?
United Therapeutics Corporation's earnings yield of 4.96% is 23% below its 5-year average of 6.45%, near the low end of its 5-year range (4.53%–9.33%).
As of Saturday, June 13, 2026. 18.73% below its 12-month average of 6.10%.
UTHR Earnings Yield Chart
UTHR Average Earnings Yield Chart
UTHR Current vs Average Earnings Yield Chart
UTHR Earnings Yield Metrics
EARNINGS YIELD
4.96%
EARNINGS YIELD AVG TTM
6.10%
EARNINGS YIELD AVG 3Y
6.92%
EARNINGS YIELD AVG 5Y
6.45%
EARNINGS YIELD AVG 10Y
8.11%
EARNINGS YIELD AVG 15Y
7.54%
EARNINGS YIELD AVG 20Y
6.50%
CURRENT VS TTM AVG
-18.73%
CURRENT VS 3Y AVG
-28.32%
CURRENT VS 5Y AVG
-23.05%
CURRENT VS 10Y AVG
-38.80%
CURRENT VS 15Y AVG
-34.20%
CURRENT VS 20Y AVG
-23.65%
UTHR Competitors' Earnings Yield
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| United Therapeutics Corporation (UTHR) | $23.17B | 4.96% | 6.10% | 6.92% | 6.45% |
| Waters Corporation (WAT) | $23.17B | 2.21% | 3.20% | 3.31% | 3.36% |
| BioNTech SE (BNTX) | $22.90B | N/A | 8.30% | 19.01% | 16.60% |
| Mettler-Toledo International Inc. (MTD) | $22.86B | 3.78% | 3.16% | 3.10% | 2.84% |
| Labcorp Holdings Inc. (LH) | $21.83B | 4.24% | 3.71% | 3.34% | 6.05% |
| Veeva Systems Inc. (VEEV) | $25.92B | 3.52% | 2.30% | 1.92% | 1.65% |
| Moderna, Inc. (MRNA) | $19.80B | N/A | 10.37% | 11.47% | 11.47% |
| DexCom, Inc. (DXCM) | $29.08B | 3.10% | 2.58% | 1.81% | 1.32% |
| Hologic, Inc. (HOLX) | $16.97B | 3.16% | 3.63% | 3.48% | 5.61% |
| Biogen Inc. (BIIB) | $29.53B | 4.67% | 6.28% | 5.94% | 5.80% |
Earnings Yield vs P/E Ratio
Earnings Yield
4.96%
EPS ÷ Price
P/E Ratio
20.2
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
- It expresses earnings relative to share price as a percentage
- It can be compared with FCF yield and dividend yield
- It can be compared with bond yields because both are percentages
- It is mathematically the inverse of the P/E ratio
United Therapeutics Corporation Earnings Yield Formula & Definition
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
United Therapeutics Corporation Earnings Yield FAQ
- What is the earnings yield for United Therapeutics Corporation (UTHR)?
- The earnings yield for UTHR stock is 4.96%.
- Is United Therapeutics Corporation's earnings yield high or low?
- United Therapeutics Corporation's earnings yield of 4.96% is 23% below its 5-year average of 6.45%, near the low end of its 5-year range (4.53%–9.33%).
- What is the TTM average earnings yield for United Therapeutics Corporation (UTHR)?
- The TTM average earnings yield for UTHR stock is 6.10%.
- What is the 3Y average earnings yield for United Therapeutics Corporation (UTHR)?
- The 3Y average earnings yield for UTHR stock is 6.92%.
- What is the 5Y average earnings yield for United Therapeutics Corporation (UTHR)?
- The 5Y average earnings yield for UTHR stock is 6.45%.
- What is the 10Y average earnings yield for United Therapeutics Corporation (UTHR)?
- The 10Y average earnings yield for UTHR stock is 8.11%.
- What is the 15Y average earnings yield for United Therapeutics Corporation (UTHR)?
- The 15Y average earnings yield for UTHR stock is 7.54%.
- What is the 20Y average earnings yield for United Therapeutics Corporation (UTHR)?
- The 20Y average earnings yield for UTHR stock is 6.50%.
United Therapeutics Corporation Earnings Yield History
| DATE | EARNINGS YIELD |
|---|---|
| 2026-06-12 | 4.96% |
| 2026-06-11 | 4.96% |
| 2026-06-10 | 4.97% |
| 2026-06-09 | 4.89% |
| 2026-06-08 | 4.97% |
| 2026-06-05 | 4.92% |
| 2026-06-04 | 4.94% |
| 2026-06-03 | 4.92% |
| 2026-06-02 | 5.01% |
| 2026-06-01 | 4.97% |
| 2026-05-29 | 4.86% |
| 2026-05-28 | 4.81% |
| 2026-05-27 | 4.74% |
| 2026-05-26 | 4.68% |
| 2026-05-22 | 4.76% |
| 2026-05-21 | 4.78% |
| 2026-05-20 | 4.80% |
| 2026-05-19 | 4.77% |
| 2026-05-18 | 4.77% |
| 2026-05-15 | 4.76% |
| 2026-05-14 | 4.70% |
| 2026-05-13 | 4.67% |
| 2026-05-12 | 4.65% |
| 2026-05-11 | 4.75% |
| 2026-05-08 | 4.79% |
| 2026-05-07 | 4.75% |
| 2026-05-06 | 4.53% |
| 2026-05-05 | 4.87% |
| 2026-05-04 | 4.79% |
| 2026-05-01 | 4.89% |
| 2026-04-30 | 4.88% |
| 2026-04-29 | 4.88% |
| 2026-04-28 | 4.89% |
| 2026-04-27 | 4.91% |
| 2026-04-24 | 4.91% |
| 2026-04-23 | 4.86% |
| 2026-04-22 | 4.85% |
| 2026-04-21 | 4.86% |
| 2026-04-20 | 4.86% |
| 2026-04-17 | 4.73% |
| 2026-04-16 | 4.80% |
| 2026-04-15 | 4.82% |
| 2026-04-14 | 4.81% |
| 2026-04-13 | 4.82% |
| 2026-04-10 | 4.87% |
| 2026-04-09 | 4.85% |
| 2026-04-08 | 4.79% |
| 2026-04-07 | 4.92% |
| 2026-04-06 | 4.98% |
| 2026-04-02 | 4.93% |
| 2026-04-01 | 4.89% |
| 2026-03-31 | 4.70% |
| 2026-03-30 | 4.73% |
| 2026-03-27 | 5.33% |
| 2026-03-26 | 5.23% |
| 2026-03-25 | 5.14% |
| 2026-03-24 | 5.24% |
| 2026-03-23 | 5.34% |
| 2026-03-20 | 5.31% |
| 2026-03-19 | 5.29% |
| 2026-03-18 | 5.25% |
| 2026-03-17 | 5.16% |
| 2026-03-16 | 5.21% |
| 2026-03-13 | 5.20% |
| 2026-03-12 | 5.23% |
| 2026-03-11 | 5.12% |
| 2026-03-10 | 5.20% |
| 2026-03-09 | 5.27% |
| 2026-03-06 | 5.83% |
| 2026-03-05 | 5.74% |
| 2026-03-04 | 5.68% |
| 2026-03-03 | 5.59% |
| 2026-03-02 | 5.42% |
| 2026-02-27 | 5.53% |
| 2026-02-26 | 5.53% |
| 2026-02-25 | 5.21% |
| 2026-02-24 | 5.57% |
| 2026-02-23 | 5.56% |
| 2026-02-20 | 5.57% |
| 2026-02-19 | 5.49% |
| 2026-02-18 | 5.54% |
| 2026-02-17 | 5.47% |
| 2026-02-13 | 5.57% |
| 2026-02-12 | 5.54% |
| 2026-02-11 | 5.55% |
| 2026-02-10 | 5.58% |
| 2026-02-09 | 5.58% |
| 2026-02-06 | 5.44% |
| 2026-02-05 | 5.51% |
| 2026-02-04 | 5.47% |
| 2026-02-03 | 5.52% |
| 2026-02-02 | 5.56% |
| 2026-01-30 | 5.62% |
| 2026-01-29 | 5.64% |
| 2026-01-28 | 5.65% |
| 2026-01-27 | 5.53% |
| 2026-01-26 | 5.57% |
| 2026-01-23 | 5.63% |
| 2026-01-22 | 5.59% |
| 2026-01-21 | 5.62% |
| 2026-01-20 | 5.64% |
| 2026-01-16 | 5.68% |
| 2026-01-15 | 5.59% |
| 2026-01-14 | 5.55% |
| 2026-01-13 | 5.53% |
| 2026-01-12 | 5.47% |
| 2026-01-09 | 5.46% |
| 2026-01-08 | 5.38% |
| 2026-01-07 | 5.24% |
| 2026-01-06 | 5.25% |
| 2026-01-05 | 5.39% |
| 2026-01-02 | 5.31% |
| 2025-12-31 | 5.42% |
| 2025-12-30 | 5.32% |
| 2025-12-29 | 5.25% |
| 2025-12-26 | 5.20% |
| 2025-12-24 | 5.13% |
| 2025-12-23 | 5.17% |
| 2025-12-22 | 5.14% |
| 2025-12-19 | 5.10% |
| 2025-12-18 | 5.21% |
| 2025-12-17 | 5.17% |
| 2025-12-16 | 5.28% |
| 2025-12-15 | 5.27% |
| 2025-12-12 | 5.34% |
| 2025-12-11 | 5.40% |
| 2025-12-10 | 5.44% |
| 2025-12-09 | 5.54% |
| 2025-12-08 | 5.50% |
| 2025-12-05 | 5.39% |
| 2025-12-04 | 5.45% |
| 2025-12-03 | 5.49% |
| 2025-12-02 | 5.56% |
| 2025-12-01 | 5.50% |
| 2025-11-28 | 5.43% |
| 2025-11-26 | 5.40% |
| 2025-11-25 | 5.43% |
| 2025-11-24 | 5.53% |
| 2025-11-21 | 5.56% |
| 2025-11-20 | 5.56% |
| 2025-11-19 | 5.54% |
| 2025-11-18 | 5.54% |
| 2025-11-17 | 5.59% |
| 2025-11-14 | 5.66% |
| 2025-11-13 | 5.71% |
| 2025-11-12 | 5.72% |
| 2025-11-11 | 5.75% |
| 2025-11-10 | 5.81% |
| 2025-11-07 | 5.88% |
| 2025-11-06 | 5.81% |
| 2025-11-05 | 5.90% |
| 2025-11-04 | 6.04% |
| 2025-11-03 | 6.02% |
| 2025-10-31 | 5.92% |
| 2025-10-30 | 5.82% |
| 2025-10-29 | 5.80% |
| 2025-10-28 | 6.17% |
| 2025-10-27 | 6.09% |
| 2025-10-24 | 6.12% |
| 2025-10-23 | 6.01% |
| 2025-10-22 | 6.08% |
| 2025-10-21 | 6.06% |
| 2025-10-20 | 5.92% |
| 2025-10-17 | 5.91% |
| 2025-10-16 | 5.92% |
| 2025-10-15 | 5.93% |
| 2025-10-14 | 5.91% |
| 2025-10-13 | 5.82% |
| 2025-10-10 | 5.82% |
| 2025-10-09 | 5.75% |
| 2025-10-08 | 5.71% |
| 2025-10-07 | 5.61% |
| 2025-10-06 | 5.65% |
| 2025-10-03 | 5.66% |
| 2025-10-02 | 5.78% |
| 2025-10-01 | 5.85% |
| 2025-09-30 | 6.11% |
| 2025-09-29 | 6.04% |
| 2025-09-26 | 5.92% |
| 2025-09-25 | 6.02% |
| 2025-09-24 | 5.84% |
| 2025-09-23 | 5.90% |
| 2025-09-22 | 6.18% |
| 2025-09-19 | 6.13% |
| 2025-09-18 | 6.25% |
| 2025-09-17 | 6.35% |
| 2025-09-16 | 6.44% |
| 2025-09-15 | 6.36% |
| 2025-09-12 | 6.33% |
| 2025-09-11 | 6.33% |
| 2025-09-10 | 6.46% |
| 2025-09-09 | 6.35% |
| 2025-09-08 | 6.49% |
| 2025-09-05 | 6.40% |
| 2025-09-04 | 6.73% |
| 2025-09-03 | 6.54% |
| 2025-09-02 | 6.33% |
| 2025-08-29 | 8.40% |
| 2025-08-28 | 8.34% |
| 2025-08-27 | 8.39% |
| 2025-08-26 | 8.29% |
| 2025-08-25 | 8.39% |
| 2025-08-22 | 8.20% |
| 2025-08-21 | 8.24% |
| 2025-08-20 | 8.36% |
| 2025-08-19 | 8.18% |
| 2025-08-18 | 8.16% |
| 2025-08-15 | 8.18% |
| 2025-08-14 | 8.21% |
| 2025-08-13 | 8.27% |
| 2025-08-12 | 8.50% |
| 2025-08-11 | 8.53% |
| 2025-08-08 | 8.50% |
| 2025-08-07 | 8.55% |
| 2025-08-06 | 8.47% |
| 2025-08-05 | 8.40% |
| 2025-08-04 | 8.76% |
| 2025-08-01 | 8.70% |
| 2025-07-31 | 9.33% |
| 2025-07-30 | 9.08% |
| 2025-07-29 | 8.42% |
| 2025-07-28 | 8.40% |
| 2025-07-25 | 8.23% |
| 2025-07-24 | 8.18% |
| 2025-07-23 | 8.20% |
| 2025-07-22 | 8.41% |
| 2025-07-21 | 8.55% |
| 2025-07-18 | 8.58% |
| 2025-07-17 | 8.43% |
| 2025-07-16 | 8.40% |
| 2025-07-15 | 8.55% |
| 2025-07-14 | 8.42% |
| 2025-07-11 | 8.48% |
| 2025-07-10 | 8.35% |
| 2025-07-09 | 8.34% |
| 2025-07-08 | 8.51% |
| 2025-07-07 | 8.63% |
| 2025-07-03 | 8.51% |
| 2025-07-02 | 8.49% |
| 2025-07-01 | 8.61% |
| 2025-06-30 | 8.72% |
| 2025-06-27 | 8.82% |
| 2025-06-26 | 8.82% |
| 2025-06-25 | 8.76% |
| 2025-06-24 | 8.64% |
| 2025-06-23 | 8.75% |
| 2025-06-20 | 8.62% |
| 2025-06-18 | 8.59% |
| 2025-06-17 | 8.73% |
| 2025-06-16 | 8.69% |
| 2025-06-13 | 8.84% |
| 2025-06-12 | 8.76% |
| 2025-06-11 | 9.07% |
| 2025-06-10 | 8.90% |
| 2025-06-09 | 7.63% |
| 2025-06-06 | 7.69% |
| 2025-06-05 | 7.84% |
| 2025-06-04 | 7.73% |
| 2025-06-03 | 7.73% |
| 2025-06-02 | 7.70% |
Showing the most recent 260 of 4,530 data points. The chart above shows the full history.
Related Metrics
About United Therapeutics Corporation
United Therapeutics Corporation, a biotechnology firm, is dedicated to discovering, developing, and bringing to market medical solutions for individuals suffering from chronic and severe, often life-threatening, illnesses. Its operations span both the United States and international markets. The company's current commercial portfolio features several key therapeutics: Remodulin, prescribed for pulmonary arterial hypertension (PAH) to lessen symptoms experienced during physical activity. Tyvaso, an inhaled form of the prostacyclin analogue treprostinil, designed to enhance exercise capacity in patients with PAH and pulmonary hypertension linked to interstitial lung disease (PH-ILD). Orenitram, a treprostinil tablet formulation, also aims to boost the exercise capabilities of PAH patients. Unituxin, a monoclonal antibody utilized in the treatment of high-risk neuroblastoma. Adcirca, an oral PDE-5 inhibitor, which helps improve exercise performance in those with PAH. United Therapeutics also maintains a robust development pipeline, including: Tyvaso DPI, a dry powder inhaler version of Tyvaso. The Remunity Pump, a compact, lightweight, and durable infusion system for treprostinil, accompanied by a separate controller. RemoPro and Ralinepag, both investigational treatments for PAH. Aurora-GT, a gene therapy product focused on regenerating blood vessels within the lungs. Clinical trials such as Tyvaso PERFECT and TETON, which are evaluating Tyvaso's efficacy in patients with World Health Organization (WHO) Group 3 pulmonary hypertension associated with chronic obstructive pulmonary disease (PH-COPD). The company has forged strategic alliances and licensing agreements with various entities, such as DEKA Research & Development Corp. for a semi-disposable subcutaneous treprostinil delivery system; MannKind Corporation for the development and licensing of treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. for the development of Ralinepag. Established in 1996, United Therapeutics Corporation is headquartered in Silver Spring, Maryland.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Martine A. Rothblatt